RepliCel Historical Balance Sheet

RP Stock  CAD 0.06  0.00  0.00%   
Trend analysis of RepliCel Life Sciences balance sheet accounts such as Net Debt of 791.7 K, Accounts Payable of 472.3 K, Cash of 56.2 K or Non Current Assets Total of 119.4 K provides information on RepliCel Life's total assets, liabilities, and equity, which is the actual value of RepliCel Life Sciences to its prevalent stockholders. By breaking down trends over time using RepliCel Life balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining RepliCel Life Sciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether RepliCel Life Sciences is a good buy for the upcoming year.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RepliCel Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About RepliCel Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of RepliCel Life Sciences at a specified time, usually calculated after every quarter, six months, or one year. RepliCel Life Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of RepliCel Life and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which RepliCel currently owns. An asset can also be divided into two categories, current and non-current.

RepliCel Life Balance Sheet Chart

At this time, RepliCel Life's Other Liabilities is fairly stable compared to the past year.

Total Assets

Total assets refers to the total amount of RepliCel Life assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in RepliCel Life Sciences books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on RepliCel Life balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of RepliCel Life Sciences are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.
Most accounts from RepliCel Life's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into RepliCel Life Sciences current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RepliCel Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
At this time, RepliCel Life's Other Liabilities is fairly stable compared to the past year.
 2021 2022 2023 2024 (projected)
Short and Long Term Debt Total34.3K41.0K813.2K487.3K
Total Assets591.8K798.2K287.8K273.4K

RepliCel Life balance sheet Correlations

0.19-0.190.490.34-0.810.12-0.150.810.00.980.3-0.290.41-0.220.99-0.530.020.58-0.310.33-0.310.13-0.230.340.19
0.19-0.140.350.20.040.06-0.290.15-0.250.22-0.210.150.29-0.310.22-0.17-0.040.41-0.4-0.09-0.550.260.050.20.11
-0.19-0.14-0.87-0.870.3-0.950.71-0.160.8-0.350.650.82-0.340.91-0.280.70.88-0.39-0.40.30.68-0.440.85-0.94-0.95
0.490.35-0.870.87-0.490.84-0.510.39-0.770.61-0.47-0.770.37-0.960.57-0.88-0.730.70.17-0.1-0.880.52-0.760.970.87
0.340.2-0.870.87-0.430.88-0.40.27-0.730.48-0.5-0.860.57-0.870.41-0.84-0.790.650.05-0.17-0.80.6-0.840.90.95
-0.810.040.3-0.49-0.43-0.340.08-0.950.08-0.8-0.140.48-0.280.29-0.810.620.19-0.660.14-0.270.28-0.110.43-0.42-0.34
0.120.06-0.950.840.88-0.34-0.580.19-0.750.28-0.68-0.850.32-0.90.2-0.73-0.940.440.4-0.32-0.680.37-0.920.930.97
-0.15-0.290.71-0.51-0.40.08-0.58-0.130.52-0.270.560.27-0.230.52-0.20.140.610.02-0.450.530.270.030.41-0.51-0.54
0.810.15-0.160.390.27-0.950.19-0.130.040.790.13-0.230.29-0.160.8-0.45-0.090.61-0.210.22-0.22-0.03-0.260.270.18
0.0-0.250.8-0.77-0.730.08-0.750.520.04-0.160.610.55-0.260.86-0.10.580.74-0.43-0.270.510.76-0.60.53-0.78-0.79
0.980.22-0.350.610.48-0.80.28-0.270.79-0.160.14-0.380.52-0.360.99-0.59-0.150.61-0.240.18-0.410.2-0.360.470.35
0.3-0.210.65-0.47-0.5-0.14-0.680.560.130.610.140.35-0.130.620.230.20.75-0.04-0.560.510.4-0.050.52-0.53-0.66
-0.290.150.82-0.77-0.860.48-0.850.27-0.230.55-0.380.35-0.220.79-0.350.860.69-0.48-0.26-0.110.58-0.480.88-0.87-0.87
0.410.29-0.340.370.57-0.280.32-0.230.29-0.260.52-0.13-0.22-0.280.43-0.31-0.320.44-0.41-0.3-0.410.38-0.430.330.43
-0.22-0.310.91-0.96-0.870.29-0.90.52-0.160.86-0.360.620.79-0.28-0.30.820.82-0.59-0.290.210.88-0.540.79-0.98-0.92
0.990.22-0.280.570.41-0.810.2-0.20.8-0.10.990.23-0.350.43-0.3-0.58-0.060.63-0.280.28-0.390.19-0.280.420.27
-0.53-0.170.7-0.88-0.840.62-0.730.14-0.450.58-0.590.20.86-0.310.82-0.580.56-0.840.05-0.240.82-0.590.74-0.88-0.77
0.02-0.040.88-0.73-0.790.19-0.940.61-0.090.74-0.150.750.69-0.320.82-0.060.56-0.33-0.430.470.62-0.290.82-0.82-0.91
0.580.41-0.390.70.65-0.660.440.020.61-0.430.61-0.04-0.480.44-0.590.63-0.84-0.33-0.410.2-0.790.55-0.440.610.5
-0.31-0.4-0.40.170.050.140.4-0.45-0.21-0.27-0.24-0.56-0.26-0.41-0.29-0.280.05-0.43-0.41-0.30.15-0.39-0.340.280.31
0.33-0.090.3-0.1-0.17-0.27-0.320.530.220.510.180.51-0.11-0.30.210.28-0.240.470.2-0.30.10.050.13-0.11-0.31
-0.31-0.550.68-0.88-0.80.28-0.680.27-0.220.76-0.410.40.58-0.410.88-0.390.820.62-0.790.150.1-0.710.57-0.83-0.74
0.130.26-0.440.520.6-0.110.370.03-0.03-0.60.2-0.05-0.480.38-0.540.19-0.59-0.290.55-0.390.05-0.71-0.320.520.45
-0.230.050.85-0.76-0.840.43-0.920.41-0.260.53-0.360.520.88-0.430.79-0.280.740.82-0.44-0.340.130.57-0.32-0.87-0.89
0.340.2-0.940.970.9-0.420.93-0.510.27-0.780.47-0.53-0.870.33-0.980.42-0.88-0.820.610.28-0.11-0.830.52-0.870.94
0.190.11-0.950.870.95-0.340.97-0.540.18-0.790.35-0.66-0.870.43-0.920.27-0.77-0.910.50.31-0.31-0.740.45-0.890.94
Click cells to compare fundamentals

RepliCel Life Account Relationship Matchups

RepliCel Life balance sheet Accounts

201920202021202220232024 (projected)
Total Assets505.5K421.0K591.8K798.2K287.8K273.4K
Total Current Liabilities1.6M2.2M1.7M2.1M1.8M1.9M
Total Stockholder Equity(4.4M)(5.1M)(6.8M)(5.9M)(4.5M)(4.3M)
Property Plant And Equipment Net6.0K4.4K3.3K2.4K967.0918.65
Net Debt425.4K41.7K(186.9K)(372.1K)754.0K791.7K
Retained Earnings(36.6M)(38.2M)(42.2M)(43.0M)(43.3M)(41.1M)
Accounts Payable640.3K1.3M602.0K817.9K416.0K472.3K
Cash23.9K34.4K221.2K413.0K59.2K56.2K
Non Current Assets Total272.2K235.3K198.8K162.5K125.7K119.4K
Cash And Short Term Investments52.7K51.6K238.4K430.3K76.4K72.6K
Net Receivables51.9K63.6K61.2K82.2K38.0K39.0K
Common Stock Shares Outstanding24.1M27.0M32.5M37.8M59.2M62.2M
Liabilities And Stockholders Equity505.5K421.0K591.8K798.2K287.8K273.4K
Other Stockholder Equity4.6M4.6M5.1M5.4M5.6M5.6M
Total Liab4.9M5.5M7.4M6.7M4.8M5.1M
Total Current Assets233.2K185.7K393.0K635.7K162.1K154.0K
Short Term Debt449.3K47.3K611.4K689.3K813.2K853.8K
Common Stock27.5M28.5M30.3M31.7M33.1M20.0M
Other Current Liab107.3K517.8K106.6K211.8K239.5K432.0K
Other Assets266.2K230.8K195.5K1.01.151.09
Non Current Liabilities Total3.4M3.2M5.8M4.6M3.0M2.1M
Other Current Assets128.7K70.5K93.4K123.2K47.7K89.2K
Net Tangible Assets(1.9M)(4.4M)(5.1M)(6.8M)(6.2M)(5.9M)
Property Plant Equipment8.2K6.0K4.4K3.3K2.9K2.8K
Net Invested Capital(2.9M)(5.0M)(6.8M)(5.9M)(5.3M)(5.6M)
Net Working Capital(1.2M)(2.1M)(1.3M)(1.4M)(1.3M)(1.4M)
Capital Stock29.0M28.5M30.3M31.7M36.4M32.6M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for RepliCel Stock Analysis

When running RepliCel Life's price analysis, check to measure RepliCel Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RepliCel Life is operating at the current time. Most of RepliCel Life's value examination focuses on studying past and present price action to predict the probability of RepliCel Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RepliCel Life's price. Additionally, you may evaluate how the addition of RepliCel Life to your portfolios can decrease your overall portfolio volatility.